Healthcare Industry News: linear accelerator
News Release - July 14, 2016
Accuray Products Continue to Receive Highest Composite User Satisfaction Ratings in Latest MD Buyline ReportSUNNYVALE, Calif., July 14, 2016 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced today that its CyberKnife® and TomoTherapy® Systems continue to set the standard for overall user satisfaction. The Accuray systems received the highest composite overall user satisfaction rating among radiation treatment delivery systems in the U.S., according to the Q2 2016 MD Buyline Market Intelligence Briefing™. The most recent ratings trend also shows Accuray has achieved the highest ratings among industry peers over the past three years.
In rating the Accuray systems, MD Buyline reports the company obtained the highest scores in a majority of categories measured including system performance, system reliability, service response time and service repair quality. CyberKnife System users also "highly recommend" the InCise™ Multileaf Collimator (MLC) noting "it makes the treatment time much more efficient." CyberKnife and TomoTherapy System users continued to "praise the high level of reliability afforded by Accuray systems."
"The independent MD Buyline report is further evidence we are succeeding with our strategy to drive innovative cancer care with a clear focus on customer satisfaction," said Joshua H. Levine, president and CEO of Accuray. "The feedback continues to validate the TomoTherapy System's functionality as a workhorse radiation oncology device while also highlighting the expanded efficiency of our next generation CyberKnife System equipped with an MLC. Our strong overall user satisfaction ratings are a major factor behind our growth in the marketplace."
For more information on the CyberKnife and TomoTherapy Systems visit www.accuray.com.
MD Buyline, an independent market intelligence organization for the healthcare industry, measures linear accelerator user satisfaction based on evaluations by more than 3,300 hospitals in its member network that use the product every day. Respondents rate how satisfied they are with products from Accuray, Elekta and Varian, using key metrics listed above along with installation and implementation, applications training, and service repair quality. (MD Buyline User Satisfaction Ratings, MD Buyline Market Intelligence Briefing™ Q2 2016) © 2016 MD Buyline, All Rights Reserved. Used with Permission July 13, 2016.
About the CyberKnife and TomoTherapy Systems
The Accuray CyberKnife M6™ Series and TomoTherapy H™ Series treatment solutions cover the entire spectrum of radiation therapy needs. The CyberKnife M6 Series enables precise, high-quality, high-dose distributions to be confidently delivered to the patient with extreme accuracy over a minimum number of treatments, reducing side effects and preserving patients' quality of life. The CyberKnife System is the only robotic full-body radiosurgery system available today. The TomoTherapy H Series efficiently enables physicians to customize treatment plans for the entire range of radiation therapy patients and disease types. Its innovative design enables treatment plans to be delivered with integrated, daily CT image guidance, enhancing accuracy and delivering highly precise, intensity-modulated radiation for optimal sparing of healthy tissue and critical structures.
Accuray Incorporated (ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsAccuray Unveils VOLO(TM) Ultra, the Latest Innovation for the Radixact(R) System, at ASTRO 2021
C-RAD and Accuray Sign Agreement to Enhance Radixact(R) System Breast Cancer Treatment Capabilities
French Hospital Network Unicancer Acquires Multiple Accuray Radixact(R) Systems with the ClearRT(TM) Helical Fan-Beam kVCT Imaging and Synchrony(R) Technologies